Decibel Therapeutics Inc. (DBTX)
NASDAQ: DBTX
· Real-Time Price · USD
4.91
-0.04 (-0.81%)
At close: Sep 22, 2023, 10:00 PM
Decibel Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -19.04M | -14.12M | -16.49M | -16.35M | -17.1M | -14.02M | -12.9M | -14.7M | -11.73M | -10.9M |
Interest Income | 976K | 878K | 660K | 374K | 95K | 63K | 52K | 33K | 75K | 33K |
Pretax Income | -18.07M | -13.24M | -15.83M | -15.97M | -17.01M | -13.96M | -12.84M | -14.67M | -11.65M | -10.87M |
Net Income | -18.14M | -13.3M | -15.94M | -16M | -17.05M | -14.02M | -12.9M | -16.4M | -11.65M | -10.87M |
Selling & General & Admin | 6.21M | 6.19M | 4.89M | 6.32M | 5.86M | 6.55M | 4.92M | 5.68M | 4.9M | 4.88M |
Research & Development | 12.83M | 7.93M | 11.59M | 10.03M | 11.24M | 7.47M | 7.98M | 9.02M | 6.83M | 6.02M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 19.04M | 14.12M | 16.49M | 16.35M | 17.1M | 14.02M | 12.9M | 14.7M | 11.73M | 10.9M |
Interest Expense | n/a | n/a | 660K | 374K | 95K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.04M | 14.12M | 16.49M | 16.35M | 17.1M | 14.02M | 12.9M | 14.7M | 11.73M | 10.9M |
Income Tax Expense | 80K | 61K | 112K | 30K | 38K | 60K | 65K | 1.73M | n/a | n/a |
Shares Outstanding (Basic) | 25.02M | 24.99M | 24.96M | 24.96M | 24.96M | 24.96M | 24.95M | 24.87M | 24.87M | 23.99M |
Shares Outstanding (Diluted) | 25.02M | 24.99M | 24.96M | 24.96M | 24.96M | 24.96M | 24.95M | 24.87M | 24.87M | 23.99M |
EPS (Basic) | -0.73 | -0.53 | -0.64 | -0.64 | -0.68 | -0.56 | -0.52 | -0.66 | -0.47 | -0.45 |
EPS (Diluted) | -0.73 | -0.53 | -0.64 | -0.64 | -0.68 | -0.56 | -0.52 | -0.66 | -0.47 | -0.45 |
EBITDA | -18.72M | -13.78M | -16.11M | -15.99M | -16.74M | -13.65M | -12.59M | -14.36M | -11.39M | -10.48M |
EBIT | -19.04M | -14M | -15.17M | -15.6M | -16.91M | -14.02M | -12.9M | -14.7M | -11.73M | -10.9M |
Depreciation & Amortization | 323K | 340K | 374K | 359K | 362K | 367K | 309K | 340K | 337K | 427K |